Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat
Authors
Keywords
-
Journal
Current Infectious Disease Reports
Volume 21, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-16
DOI
10.1007/s11908-019-0706-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model
- (2019) Shun Xin Wang-Lin et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
- (2019) Tianshui Niu et al. Antimicrobial Resistance and Infection Control
- Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections
- (2019) Khalid Eljaaly et al. DRUGS
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Identification of a novel plasmid carries mcr-4.3 in Acinetobacter baumannii from China
- (2019) Furong Ma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug‐Resistant Gram‐Negative Bacterial Infections in Solid Organ Transplant Recipients – Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Stephanie M. Pouch et al. CLINICAL TRANSPLANTATION
- Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit
- (2019) Ying Xu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Implications of Bacteriophage- and Bacteriophage Component-Based Therapies For The Clinical Microbiology Laboratory
- (2019) Katherine M. Caflisch et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Advances in Diagnostic Testing that Impact Infection Prevention and Antimicrobial Stewardship Programs
- (2019) Kaede V. Sullivan Current Infectious Disease Reports
- Specific and Selective Bacteriophages in the Fight against Multidrug-resistant Acinetobacter baumannii
- (2019) Natalia Bagińska et al. VIROLOGICA SINICA
- In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from United States Hospitals and Comparative Activity of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes
- (2018) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
- (2018) Lynn E. Connolly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities
- (2018) Jason M. Pogue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe as Part of the 2016 SENTRY Antimicrobial Surveillance Program
- (2018) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China
- (2018) Yunxing Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii
- (2018) T. Amat et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii
- (2018) C.-A. Liang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals
- (2018) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii
- (2018) Harald Seifert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†
- (2018) Peter M Hawkey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fitness cost of mcr-1-mediated polymyxin resistance in Klebsiella pneumoniae
- (2018) Sue C Nang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Salvage tigecycline in high risk febrile neutropenic patients with hematological malignancies: a prospective multicenter study
- (2018) Xin-Ping Zhou et al. LEUKEMIA & LYMPHOMA
- Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
- (2018) Stephanie LaVergne et al. Open Forum Infectious Diseases
- DETECTION OF AMINOGLYCOSIDE AND QUINOLONE RESISTANCE GENES AND EVALUATION OF POLYMYXIN B SUSCEPTIBILITY PROFILE IN ACINETOBACTER BAUMANNII CLINICAL ISOLATES IN TEHRAN, IRAN DURING 2015-2016
- (2018) Mohsen Heidary Mediterranean Journal of Hematology and Infectious Diseases
- Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects
- (2018) Keith A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
- (2018) Muhammad Asif et al. Infection and Drug Resistance
- OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains
- (2018) Yunxing Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial
- (2018) Yaakov Dickstein et al. CLINICAL INFECTIOUS DISEASES
- Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories part of the COMBACTE network: a COMBACTE LAB-Net survey
- (2018) T Kostyanev et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- 1377. Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms
- (2018) Rodrigo E Mendes et al. Open Forum Infectious Diseases
- International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
- (2017) Antoni Torres et al. EUROPEAN RESPIRATORY JOURNAL
- Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2017) Kirati Kengkla et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
- (2017) Justin R. Lenhard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy of sulbactam for the treatment of Acinetobacter baumannii complex infection: A systematic review and meta-analysis
- (2017) Haojun Chen et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
- (2017) Travis B Nielsen et al. JOURNAL OF INFECTIOUS DISEASES
- First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate
- (2017) Mohamed H. Al-Agamy et al. Microbial Drug Resistance
- The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
- (2017) John E. Mazuski et al. Surgical Infections
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- A New Take on an Old Remedy: Generating Antibodies against Multidrug-Resistant Gram-Negative Bacteria in a Postantibiotic World
- (2017) Michael P. Motley et al. mSphere
- Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β-lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β-lactamases
- (2017) Jason Lickliter et al. Open Forum Infectious Diseases
- Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
- (2016) Takayuki Katsube et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Inhaled Antibiotics for Gram-Negative Respiratory Infections
- (2016) Eric Wenzler et al. CLINICAL MICROBIOLOGY REVIEWS
- Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
- (2016) Li-Yang Hsu et al. CLINICAL MICROBIOLOGY REVIEWS
- Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages
- (2016) Agata Anna Cisek et al. CURRENT MICROBIOLOGY
- Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia
- (2016) Eric Wenzler et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections
- (2016) Thatiany Cevallos Menegucci et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
- (2016) Wentao Ni et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Detection of the plasmid-mediated quinolone resistance determinants in clinical isolates ofAcinetobacter baumanniiin China
- (2016) Haifei Yang et al. JOURNAL OF CHEMOTHERAPY
- Tetracycline Antibiotics and Resistance
- (2016) Trudy H. Grossman Cold Spring Harbor Perspectives in Medicine
- Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit
- (2016) Yu-Huai Ho et al. PLoS One
- Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline
- (2015) Laura Honeyman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
- (2015) Cristina García-Salguero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Ribosomal S10 Protein Is a General Target for Decreased Tigecycline Susceptibility
- (2015) Kathryn Beabout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A PmrB-Regulated Deacetylase Required for Lipid A Modification and Polymyxin Resistance in Acinetobacter baumannii
- (2015) Chui-Yoke Chin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Task force on management and prevention of Acinetobacter baumannii infections in the ICU
- (2015) José Garnacho-Montero et al. INTENSIVE CARE MEDICINE
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population pharmacokinetic–pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections
- (2015) Yuta Yokoyama et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
- (2014) Marie Abdallah et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii
- (2014) Sarunyou Chusri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tetracycline antibiotics and resistance mechanisms
- (2014) Fabian Nguyen et al. BIOLOGICAL CHEMISTRY
- Bad Bugs Need Old Drugs: A Stewardship Program's Evaluation of Minocycline for Multidrug-Resistant Acinetobacter baumannii Infections
- (2014) Debra A. Goff et al. CLINICAL INFECTIOUS DISEASES
- Carbapenem-Resistance in Gram-Negative Bacilli and Intravenous Minocycline: An Antimicrobial Stewardship Approach at the Detroit Medical Center
- (2014) Jason M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs
- (2014) Karri A. Bauer et al. CLINICAL INFECTIOUS DISEASES
- OXA -Lactamases
- (2014) B. A. Evans et al. CLINICAL MICROBIOLOGY REVIEWS
- Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections
- (2014) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems
- (2013) Oren Zusman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
- (2013) J. A. Sutcliffe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase
- (2013) Q. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- TEM-1 -lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii
- (2013) L. Krizova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Metallo-β-lactamase structure and function
- (2012) Timothy Palzkill Annals of the New York Academy of Sciences
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ThepmrCABOperon Mediates Polymyxin Resistance inAcinetobacter baumanniiATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A
- (2011) Luis A. Arroyo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
- (2011) Alejandro Beceiro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
- (2010) S. Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
- (2010) J. H. Moffatt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- GES Extended-Spectrum -Lactamases in Acinetobacter baumannii Isolates in Belgium
- (2010) P. Bogaerts et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
- (2010) Nicola C. Gordon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tetracycline Susceptibility Testing and Resistance Genes in Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus Complex from a U.S. Military Hospital
- (2009) K. S. Akers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection of KPC in Acinetobacter spp. in Puerto Rico
- (2009) I. E. Robledo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
- (2009) M. D. Adams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- First report of qnrB-producing Enterobacter cloacae and qnrA-producing Acinetobacter baumannii recovered from Algerian hospitals
- (2007) Abdelaziz Touati et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started